{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:30:32Z","timestamp":1792200632799,"version":"4.4.0"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Prostate MRI has an established role in early diagnosis, staging, and active surveillance of prostate cancer (PCa), and its demand continues to rise. Moreover, the growing use of active surveillance for patients with low-risk and favourable intermediate-risk prostate cancer, along with ongoing research into MRI-based screening, is expected to further increase the need for MRI follow-up. Routine use of bi-parametric MRI and more selective, evidence-based administration of gadolinium contrast agents may help reduce the growing strain on MRI services. This special report explores scenarios in which contrast enhancement can improve diagnostic confidence, as well as situations where it may be safely omitted. It also examines the potential of on-table monitoring to guide patient-specific contrast administration, highlighting recent evidence suggesting this approach could reduce contrast use in three out of four men without compromising cancer detection or biopsy rates. Finally, the report outlines future research directions aimed at optimising scan times and contrast use in prostate cancer MRI.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Key Points<\/jats:title>\n            <jats:p>\n              <jats:bold>\n                <jats:italic>Question<\/jats:italic>\n              <\/jats:bold>\n              <jats:italic>With the growing demand for prostate MRI, how can we optimise scanner and specialist time, minimise gadolinium use, and still maintain high diagnostic accuracy<\/jats:italic>?<\/jats:p>\n            <jats:p>\n              <jats:bold>\n                <jats:italic>Findings<\/jats:italic>\n              <\/jats:bold>\n              <jats:italic>Syer et al demonstrate the feasibility of using on-table monitoring to reduce the number of contrast-enhanced prostate MRI exams by 76%, without compromising cancer detection or biopsy rates<\/jats:italic>.<\/jats:p>\n            <jats:p>\n              <jats:bold>\n                <jats:italic>Clinical relevance<\/jats:italic>\n              <\/jats:bold>\n              <jats:italic>While promising, the effectiveness of on-table monitoring for guiding contrast-enhanced acquisitions requires further validation. Tailoring imaging protocols to individual patient risk profiles will be essential for optimising resource use while maintaining diagnostic quality<\/jats:italic>.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00330-025-11755-2","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T07:54:55Z","timestamp":1750060495000},"page":"5710-5713","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Personalised prostate MRI: tailoring contrast medium use in an era of increasing demand"],"prefix":"10.1007","volume":"35","author":[{"given":"Georgios","family":"Agrotis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Ursprung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9804-0603","authenticated-orcid":false,"given":"Ivo G.","family":"Schoots","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,16]]},"reference":[{"key":"11755_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-023-10284-2","volume":"23","author":"B Hofmann","year":"2023","unstructured":"Hofmann B, Brandsaeter I\u00d8, Kjelle E (2023) Variations in wait times for imaging services: a register-based study of self-reported wait times for specific examinations in Norway. BMC Health Serv Res 23:1287. https:\/\/doi.org\/10.1186\/s12913-023-10284-2","journal-title":"BMC Health Serv Res"},{"key":"11755_CR2","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1056\/NEJMoa2209454","volume":"387","author":"J Hugosson","year":"2022","unstructured":"Hugosson J, M\u00e5nsson M, Wallstr\u00f6m J et al (2022) Prostate cancer screening with PSA and MRI followed by targeted biopsy only. N Engl J Med 387:2126\u201337. https:\/\/doi.org\/10.1056\/NEJMoa2209454","journal-title":"N Engl J Med"},{"key":"11755_CR3","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1056\/NEJMoa2100852","volume":"385","author":"M Eklund","year":"2021","unstructured":"Eklund M, J\u00e4derling F, Discacciati A et al (2021) MRI-targeted or standard biopsy in prostate cancer screening. N Engl J Med 385:908\u201320. https:\/\/doi.org\/10.1056\/NEJMoa2100852","journal-title":"N Engl J Med"},{"key":"11755_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2214\/AJR.20.24268","volume":"216","author":"IG Schoots","year":"2021","unstructured":"Schoots IG, Barentsz JO, Bittencourt LK et al (2021) PI-RADS committee position on MRI without contrast medium in biopsy-naive men with suspected prostate cancer: narrative review. AJR Am J Roentgenol 216:3\u201319. https:\/\/doi.org\/10.2214\/AJR.20.24268","journal-title":"AJR Am J Roentgenol"},{"key":"11755_CR5","doi-asserted-by":"publisher","unstructured":"Syer T, Carmo B, Sanmugalingam N et al (2025) On-table monitoring of prostate MRI could enable tailored utilisation of gadolinium contrast. Eur Radiol. https:\/\/doi.org\/10.1007\/s00330-025-11479-3","DOI":"10.1007\/s00330-025-11479-3"},{"key":"11755_CR6","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.eururo.2024.09.035","volume":"87","author":"JJ Twilt","year":"2025","unstructured":"Twilt JJ, Saha A, Bosma JS et al (2025) Evaluating biparametric versus multiparametric magnetic resonance imaging for diagnosing clinically significant prostate cancer: an international, paired, noninferiority, confirmatory observer study. Eur Urol 87:240\u201350. https:\/\/doi.org\/10.1016\/j.eururo.2024.09.035","journal-title":"Eur Urol"},{"key":"11755_CR7","unstructured":"Kasivisvanathan K (2024) Comparison of biparametric and multiparametric magnetic resonance imaging for prostate cancer detection: the PRIME Study (NCT04571840). European Association of Urology Paris, France"},{"key":"11755_CR8","doi-asserted-by":"publisher","unstructured":"Padhani AR, Papanikolaou N (2025) AI and human interactions in prostate cancer diagnosis using MRI. Eur Radiol. https:\/\/doi.org\/10.1007\/s00330-025-11498-0","DOI":"10.1007\/s00330-025-11498-0"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11755-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-025-11755-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11755-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T15:08:47Z","timestamp":1755097727000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-025-11755-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,16]]},"references-count":8,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["11755"],"URL":"https:\/\/doi.org\/10.1007\/s00330-025-11755-2","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,16]]},"assertion":[{"value":"26 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Dr Ivo G. Schoots.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"S.U. is a scientific editorial board member of European Radiology (section: Urogenital), as such, he did not participate in the selection or review processes for this article. The remaining authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was not required for this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was not required.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"N\/A.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}